Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Aparna Biosciences Corporation
Profile last edited on: 8/7/11      CAGE: 4WG57      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2007
First Award
2008
Latest Award
2009
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

12111 Parklawn Drive Suite 125
Rockville, MD 20852
   (301) 770-2101
   N/A
   www.aparnabio.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

AparnaBio is a privately held biotechnology company formed to pursue to develop biomedical nanoparticle technology and products for research and treatment of human disease. The firm is developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers. They have launched InVivoPlexTM – TUMOR reagent system for in vivo delivery of siRNA and gene expression plasmids for research us

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
2
Conversion Rate
66.67%
Phase I Dollars
$902,609
Phase II Dollars
$535,000
Total Awarded
$1,437,609

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2009 1 NIH $367,609
Project Title: Dual Antigen Nanoparticle Vaccine System For Bacillus Infectious Disease
2009 2 NIH $599,200
Project Title: Hybrid Synthetic Targeted Lenti-Vlp Nanoparticle For Gene Delivery
2009 2 NIH $470,800
Project Title: In Vivo Rnai Nanoparticle Cancer Gene Function Reagent

Key People / Management

  Martin C Woodle -- Chief Executive and Scientific Officer, Co-Founder

  Yijia Liu -- Director of Biology

  Puthupparampil V Scaria -- Vice President of Research & Development, Co-founder

Company News

There are no news available.